ClouDr Group (HKSE:09955) Earnings per Share (Diluted) : HK$-0.66 (TTM As of Dec. 2023)

View and export this data going back to 2022. Start your Free Trial

What is ClouDr Group Earnings per Share (Diluted)?

ClouDr Group's Earnings per Share (Diluted) for the six months ended in Dec. 2023 was HK$-0.34. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was HK$-0.66.

ClouDr Group's EPS (Basic) for the six months ended in Dec. 2023 was HK$-0.34. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2023 was HK$-0.66.

ClouDr Group's EPS without NRI for the six months ended in Dec. 2023 was HK$-0.34. Its EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2023 was HK$-0.66.

During the past 3 years, the average EPS without NRIGrowth Rate was 52.10% per year.

During the past 5 years, ClouDr Group's highest 3-Year average EPS without NRI Growth Rate was 52.10% per year. The lowest was -78.00% per year. And the median was -12.95% per year.

ClouDr Group Earnings per Share (Diluted) Historical Data

The historical data trend for ClouDr Group's Earnings per Share (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ClouDr Group Earnings per Share (Diluted) Chart

ClouDr Group Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Earnings per Share (Diluted)

-1.09

-5.98

-8.92

-6.28

-0.66

ClouDr Group Semi-Annual Data
	Dec19	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Earnings per Share (Diluted)	Get a 7-Day Free Trial			-3.48	-2.46	-0.87	-0.32	-0.34

Competitive Comparison of ClouDr Group's Earnings per Share (Diluted)

For the Medical Distribution subindustry, ClouDr Group's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ClouDr Group's PE Ratio Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, ClouDr Group's PE Ratio distribution charts can be found below:

* The bar in red indicates where ClouDr Group's PE Ratio falls into.

ClouDr Group Earnings per Share (Diluted) Calculation

Earnings Per Share (EPS) is the amount of earnings per outstanding share of the company's stock. In calculating earnings per share, the dividends of preferred stocks need to subtracted from the total net income first.

ClouDr Group's Earnings Per Share (Diluted) for the fiscal year that ended in Dec. 2023 is calculated as

Diluted Earnings Per Share (A: Dec. 2023 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Diluted Average)
	=	(-353.362	-	0)	/	540.820
	=	-0.65

ClouDr Group's Earnings Per Share (Diluted) for the quarter that ended in Dec. 2023 is calculated as

Diluted Earnings Per Share (Q: Dec. 2023 )	=	(Net Income	-	Preferred Dividends	/	Shares Outstanding (Diluted Average)
	=	(-182.73	-	0)	/	549.417
	=	-0.33

Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$-0.66

Companies also reported diluted shares in their financial reports. Diluted shares include the shares of convertibles or warrants outstanding.

ClouDr Group (HKSE:09955) Earnings per Share (Diluted) Explanation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

ClouDr Group Earnings per Share (Diluted) Related Terms

Thank you for viewing the detailed overview of ClouDr Group's Earnings per Share (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.

ClouDr Group (HKSE:09955) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » ClouDr Group Ltd (HKSE:09955) » Definitions » Earnings per Share (Diluted)

Comparable Companies

Traded in Other Exchanges

H3L:Germany

Address

No. 998 Wenyi West Road (Haichuang Yuan), Wuchang Street, Rooms 501, 5th Floor, Building 12, Yuhang District, Zhejiang Province, Hangzhou, CHN

Website

https://www.cloudr.cn

ClouDr Group Ltd provides supplies and SaaS to hospitals and pharmacies, digital marketing services to pharmaceutical companies, and online consultation and prescriptions to patients, all centered around chronic condition management. Its offerings include in-hospital solutions, pharmacy solutions, and individual chronic condition management solutions. The company's in-hospital solution consists of sales of medical devices, consumables and pharmaceuticals, hospital SaaS, and digital marketing services to pharmaceutical companies. It generates revenues from sales of hospital and pharmacy supplies and individual chronic condition management products.

Executives

Trident Trust Company (hk) Limited	2301 Trustee
Data Vantage Development Limited	2201 Interest of corporation controlled by you
Kuang Ming	2201 Interest of corporation controlled by you
Prime Forest Assets Limited	2101 Beneficial owner
Shang Hai Qi Ji Ke Ji He Huo Qi Ye You Xian He Huo
Zhao Yin Jin Rong Kong Gu Shen Zhen You Xian Gong Si
Zhao Yin Guo Ji Jin Rong You Xian Gong Si
Zhao Yin Guo Ji Jin Rong Kong Gu You Xian Gong Si
Zhao Yin Guo Ji Jin Rong Kong Gu Shen Zhen You Xian Gong Si
Ho Chi Sing	2201 Interest of corporation controlled by you
China Merchants Bank Co., Ltd.
Zhou Quan	2201 Interest of corporation controlled by you
Idg China Venture Capital Fund Gp Iv Associates Ltd.	2201 Interest of corporation controlled by you
Haoyuan Health Limited	2101 Beneficial owner
Yass Jeffrey Steven

ClouDr Group (HKSE:09955) Headlines

No Headlines